What is Auron Therapeutics worth?
$106.3Mlast known valuation
Auron Therapeutics last raised $27.3M in its Early Stage VC (Dec 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 4 rounds
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Auron Therapeutics
Create free account
No card required
Funding history
4 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2024 | Early Stage VC | $27.3M | ▮ | ▮ |
| Jul 2022 | Early Stage VC | $38.4M | ▮ | ▮ |
| Dec 2020 | Early Stage VC | $15.4M | ▮ | ▮ |
| Jun 2018 | Debt | $660K | ▮ | ▮ |
How Auron Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Auron Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Auron Therapeutics worth?
- Auron Therapeutics's last known valuation is $106.3M.
- How much has Auron Therapeutics raised?
- Auron Therapeutics has raised $90.7M in total funding across 4 recorded rounds.
- When did Auron Therapeutics last raise?
- Auron Therapeutics last raised in Dec 2024 (Early Stage VC), raising $27.3M.